Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Keratinocyte growth factor active polypeptide and application thereof

A technology for growth factor activity and keratinocytes, which is applied in the field of keratinocyte growth factor active polypeptides, and can solve problems such as no active polypeptide gels

Pending Publication Date: 2022-04-08
PLASTIC SURGERY HOSPITAL CHINESE ACAD OF MEDICAL SCI
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

But at present, there is no relevant report on the use of keratinocyte growth factor in the preparation of active polypeptide gels

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Keratinocyte growth factor active polypeptide and application thereof
  • Keratinocyte growth factor active polypeptide and application thereof
  • Keratinocyte growth factor active polypeptide and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0032] Embodiment 1: Screening of KGF active polypeptide sequence

[0033] Coat the 96-well plate with human KGF monoclonal antibody, add phage random heptapeptide library (purchased from NEB Company, USA) and incubate overnight at 4°C, wash the plate 10 times with TBST, and wash the plate with elution buffer (0.2mol / L Glycine-HCl , pH value of 2.2, 0.1% BSA) to elute the bound phage, neutralization buffer (1mol / L Tris-HCl, pH value of 9.1) quickly neutralizes the eluate.

[0034] E.coli ER2738 host bacteria were used to amplify the eluate for the next round of screening. In the same way, three rounds of screening were performed on the eluate from each round. Titer determination was carried out on the eluate of the fourth round, phage coeruleus was randomly selected, amplified, and adjusted to 2.0×10 13 pfu / mL.

[0035] The ELISA method and the human KGF immunoassay kit (purchased from R&D Company, USA) were used to detect the binding ability of the monoclonal phage accordi...

Embodiment 2

[0047] Embodiment 2: the synthesis of KGF active polypeptide

[0048] The KGF polypeptide sequence obtained by screening in Example 1 was sent to Wuhan Minghao Biotechnology Co., Ltd. for the synthesis of KGF active short peptide, purified to 98% purity, and then the C-terminus of the polypeptide was amidated and blocked to enhance the stability of the active polypeptide ; Rhodamine laser dye labeling of the N-terminus of the polypeptide is used to identify the affinity of the active polypeptide to epidermal cells and to detect whether it can be combined with epidermal cells. Prepared into freeze-dried powder and stored at -20°C.

Embodiment 3

[0049] Embodiment 3: In vivo and in vitro experiments of KGF active polypeptide

[0050] The cultured epidermal cells were intervened with KGF active peptides, because the KGF active peptides were labeled with rhodamine laser dye, and the results of immunofluorescence detection showed that the KGF active peptides could combine with the specific receptor KGFR on the epidermal cells.

[0051] The KGF active polypeptide was further co-cultured with human epidermal cells for in vitro experiments, and the effect of the KGF active polypeptide on the proliferation of epidermal cells was detected by the CCK-8 method. The results showed that the KGF active polypeptide could promote the proliferation of epidermal cells in a concentration-dependent manner. RT-PCR and Western-blot were used to detect the expression level of the specific receptor KGFR on the epidermal cells, and the results showed that the KGF active polypeptide could promote the expression of KGFR on the epidermal cells. ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a keratinocyte growth factor active polypeptide and application thereof, and belongs to the technical field of keratinocyte growth factor active polypeptides. The nucleotide sequence of the keratinocyte growth factor active polypeptide is as shown in SEQ ID NO.54, and the amino acid sequence of the keratinocyte growth factor active polypeptide is as shown in SEQ ID NO.55. The invention also discloses an application of the keratinocyte growth factor active polypeptide in preparation of drugs for wound healing. The KGF gene sequence is obtained by screening a KGF key sequence by applying a phage random polypeptide library, and KGF active polypeptide can be directly synthesized in vitro and can be massively synthesized in a short time, so that the production cost is greatly reduced.

Description

technical field [0001] The invention relates to a keratinocyte growth factor active polypeptide and an application thereof, belonging to the technical field of keratinocyte growth factor active polypeptides. Background technique [0002] Wound healing is a complex process of repairing tissue defects. Abnormal wound healing will lead to chronic refractory wounds, which is a clinical problem that needs to be solved urgently. Topical application of growth factors helps to promote wound healing, but currently used growth factor products are expensive, have a short biological half-life, poor stability, are easily affected by the local environment of the wound, and are difficult to achieve the expected therapeutic effect, which limits their wide application. [0003] At present, the research and application of peptides have reached an unprecedented level of prosperity. Compared with natural protein, it has the advantages of smaller molecular weight, single function, less side eff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/475C12N15/12A61K38/18A61K9/06A61K9/107A61K47/14A61K47/26A61K47/32A61K47/36A61P17/02A61P29/00
Inventor 宗宪磊杜宏靳小雷宋国栋
Owner PLASTIC SURGERY HOSPITAL CHINESE ACAD OF MEDICAL SCI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com